BackBristol-Myers Squibb Company Overview

Bristol-Myers Squibb Company Receivables

Track Bristol-Myers Squibb Company's receivables ($11B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$10.55B

Peer trimmed avg / median

Loading

Bristol-Myers Squibb Company Receivables History

Loading

Bristol-Myers Squibb Company vs. peers: Receivables Comparison

Loading

Bristol-Myers Squibb Company Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bristol-Myers Squibb Company (0R1F.L) FAQ

Bristol-Myers Squibb Company (0R1F.L) currently reports a receivables of $11B as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Bristol-Myers Squibb Company's receivables history and peer comparisons.

Bristol-Myers Squibb Company's receivables changed from $0 to $11B (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bristol-Myers Squibb Company reported $11B in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $11B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bristol-Myers Squibb Company, and consider following 0R1F.L for alerts when major investors trade the stock.

Bristol-Myers Squibb Company is classified in the Healthcare sector. On receivables, it currently shows $11B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 0R1F.L with unrelated industries.